Scope of the Report
As per the scope of the report, contraceptive drugs and devices are the drugs and devices used for birth control. Contraception is more commonly known as fertility and birth control is described as the method used to avoid pregnancy. These devices and drugs function by changing the mechanism of ovulation or by acting as a physical barrier between the sperm and ovum. The proper use of contraceptives, such as female and male condoms also prevents the spread of sexually transmitted diseases.
Key Market Trends
Oral Contraceptives is Estimated to have Largest Share in the Segmentation by Drugs over the Forecast Period
Oral contraceptive pills are seen as the easiest method of contraception in the industry. They act by prohibiting implantation within the uterus if taken within 2-3 days of having unsafe sexual contact. The simplicity of their usage makes them an ideal contraceptive in the market. These are easily marketed across large regions by global companies and thus easily consumed by a large section of the population, globally. These factors are expected to contribute to the growth of the market over the forecast period. The other forms of contraceptive drugs, such as topical and injectable contraceptives have also witnessed a strong market demand.
North America has been Reported with the Largest Share and Consistent Growth over the Forecast Period.
North America is expected to register a high growth, owing to the presence of sophisticated healthcare infrastructure, the high adoption rate of contraceptive drugs, and the rising number of government initiatives that help in increasing the overall market. A large section of the women population represents the reproductive age in the United States as well as Canada. With that, a significant size of the population is at risk of unintended pregnancy, as their partners do not use a contraceptive method, correctly and consistently. The awareness regarding these products is also high with considerable support being provided by several hospitals to control the patients affected by its misuse. Moreover, the distribution channel of several companies is well established across the United States and Canada, which overall drives the market and contributes to the largest share, over the forecast period.
Competitive Landscape
Over the forecast period, most of the domestic and international players are found focusing on the emerging market and these countries are growing rapidly in the contraceptive drugs and devices market.
Table of Contents
1. INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidence of the STDs
4.2.2 Increasing Rate of Unintended Pregnancies
4.2.3 Rise in Government Initiatives
4.3 Market Restraints
4.3.1 High Cost of Devices and Treatment
4.3.2 Side Effects Associated with the Use of Contraceptive Drugs and Devices
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Products
5.1.1 By Drugs
5.1.1.1 Oral Contraceptives
5.1.1.2 Topical Contraceptives
5.1.1.3 Contraceptive Injectable
5.1.2 By Device
5.1.2.1 Condoms
5.1.2.2 Diaphragms
5.1.2.3 Cervical Caps
5.1.2.4 Sponges
5.1.2.5 Vaginal Rings
5.1.2.6 IUD
5.1.2.7 Other Devices
5.2 By Gender
5.2.1 Male
5.2.2 Female
5.3 Geography
5.3.1 North America
5.3.1.1 US
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 UK
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bayer AG
6.1.2 Pfizer Inc.
6.1.3 Merck & Co. Inc.
6.1.4 Teva Pharmaceuticals Ltd
6.1.5 Agile Therapeutics
6.1.6 Allergan PLC
6.1.7 Ani Pharmaceuticals Inc.
6.1.8 Church & Dwight Co. Inc.
6.1.9 Fuji Latex Co. Ltd
6.1.10 Johnson & Johnson Ltd
*List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
MARKET SEGMENTATION
By Products
By Drugs
Oral Contraceptives
Topical Contraceptives
Contraceptive Injectable
By Device
Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
IUD
Other Devices
By Gender
Male
Female
Geography
North America
US
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America